Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival

Overview of attention for article published in Breast Cancer Research, March 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer

Article in ESMO Open (April 2024)

Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis

Article in Breast Cancer Research and Treatment (March 2024)

HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast

Article in Targeted Oncology (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.